Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Sep 9, 2005
Trial Information
Current as of September 01, 2025
Completed
Keywords
ClinConnect Summary
Photodynamic therapy for oral leukoplakia and erythroleukoplakia
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with leukoplakia or erythroleukoplakia
- Exclusion Criteria:
- • oral cancers
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Taipei, , Taiwan
Patients applied
Trial Officials
Chun-Pin Chiang, DMSc
Principal Investigator
National Taiwan University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials